Guide

Valuing potential cures: An examination of ICER’s approach to assessing high-impact single and short-term therapies

Cell and gene therapies hold the promise to revolutionize healthcare by introducing groundbreaking advancements for patients with diseases that were previously thought incurable. Given the unique characteristics and curative potential of these therapies, it is crucial that US healthcare decision-makers apply evidence-based methods when assessing the value of these treatments to promote meaningful patient access to needed medications while maintaining health system sustainability.

Recognizing the distinctive attributes of cell and gene therapies, the Institute for Clinical and Economic Review (ICER) released methods adaptations to its value assessment framework for assessing high-impact single and short-term therapies (SST). Cencora examined the underlying methodology of ICER’s SST framework and identified important considerations related to ICER’s application of these methods in its assessments. 

brief
Download our issue brief that highlights the importance of:
brief
  • Applying fit-for-purpose, evidence-based value assessment methods when evaluating the value of cell and gene therapies
  • Identifying opportunities to address methodological limitations associated with ICER’s SST framework
brief

White paper

The Inflation Reduction Act (IRA) and its implications for intellectual property incentives to develop drugs for select populations

Webinar

The Missing PIEce: Best Practices for Implementing Pre-Approval Information Exchange (PIE) in a Payer Communication Plan

Article

Interview: Evolving and expanding global consulting with local expertise

We’re here to help

Connect with our team today to learn more about how Cencora is helping to shape the future of healthcare.

Cencora.com is providing automated translations to assist in reading the website in languages other than English. For these translations, reasonable efforts have been made to provide an accurate translation, however, no automated translation is perfect nor is it intended to replace human translators. These translations are provided as a service to users of Cencora.com and are provided "as is." No warranty of any kind, either expressed or implied, is made as to the accuracy, reliability, or correctness of any of these translations made from English into any other language. Some content (such as images, videos, Flash, etc.) may not be accurately translated due to the limitations of the translation software.

Any discrepancies or differences created in translating this content from English into another language are not binding and have no legal effect for compliance, enforcement, or any other purpose. If any errors are identified, please contact us. If any questions arise related to the accuracy of the information contained in these translations, please refer to the English version of the page.